Country Profile

Hong Kong

Hong Kong is a growing market for Indian pharmaceuticals — $47.1M in FY 2025–26. Medicines accounts for 73% of shipments, with vaccines contributing $297K.

🇭🇰 $47.1M · 1.2× growth since FY2015 · 1.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$47.1M
Exports FY2025–26 DGCIS
1.2×
Growth FY2015→2026
1.5%
CAGR FY2015→2026
73%
Medicines Share
5
Product Categories Supplied
Hong Kong is a growing market for Indian pharmaceuticals — $47.1M in FY 2025–26. Medicines accounts for 73% of shipments, with vaccines contributing $297K.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $34.3M (73.0%) Medicine Ingredients $9.59M (20.4%) Surgical & Hospital Supplies $1.65M (3.5%) Traditional & Herbal $1.20M (2.6%) Vaccines $297K (0.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Hong Kong in the RBI overseas direct investment dataset (2011–2026).